A multi-centre randomised STUdy evaluating the impact of a prognostic model for Management of BLunt chest wall trauma patients: STUMBL2 Trial

Following the successful completion of the STUMBL Feasibility Trial, we are now in a position to progress this research work to STUMBL2 Trial. Over the last ten years, we have developed and validated a prognostic model which can be used to assist in the management of blunt chest wall trauma patients in the ED. The score is applicable to isolated blunt chest wall trauma, where the patient has no immediately life-threatening injuries, but is at risk of developing complications in the next 48-72 hours. The STUMBL Score is composed of five simple predictors; patient age, number of rib fractures, presence of pre-existing chronic lung disease, use of pre-injury anti-coagulants and oxygen saturations of initial assessment in the ED. The total score then guides the clinician as to the most appropriate location for patient management; home, ward or critical care.

Through the completion of the feasibility trial, we have tested all the methods that will be used in the fully powered STUMBL2 Trial. The trial will use a cluster randomised, stepped-wedge design and will run across the UK, with participating sites acting as controls for a period of time (using no model), before moving into the intervention period (using the model to manage blunt chest wall trauma patients). The aim is test whether the STUMBL Score works in clinical practice and a number of patient and resource outcomes will be investigated.

For further details, contact the trial Chief Investigator: Ceri Battle or Twitter: @ceribattle / @stumbl_trial   

For more details on the study click here


Share this page